Chemotherapy and Atezolizumab for Patients with Extensive Stage Small Cell Lung Cancer (SCLC) with Untreated Brain Metastases (HCRN-LUN19-247)
Clinical Trial Grant
Awarded By
Genentech, Inc.
Start Date
December 7, 2020
End Date
May 30, 2024
Awarded By
Genentech, Inc.
Start Date
December 7, 2020
End Date
May 30, 2024